Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-09-13
2008-12-30
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07470514
ABSTRACT:
The present invention provides a new method for detecting, diagnosing, monitoring, staging and prognosticating prostate cancer.
REFERENCES:
patent: 5506106 (1996-04-01), Croce et al.
patent: WO 98/36054 (1998-08-01), None
patent: WO 99/00498 (1999-01-01), None
patent: WO 00/55174 (2000-09-01), None
patent: WO 00/55174 (2000-09-01), None
patent: WO 01/51633 (2001-07-01), None
Stanton, P et al, 1994, Br J Cancer, 70: 427-433.
Iehle, C et al, 1999, J Steroid Biochem Mol Biol, 68: 189-195.
Abbaszadegan, M R, et al, 1994, Cancer Res, 54: 4676-4679.
Kibel, AS et al, 2000, J urol, 164(1): 192-6.
Dong et al, 2000, Cancer Research, 60: 3880-3883.
Zhau, HE, 1994, J Cell Biochem, Suppl 19: 208-216.
Ren, C et al, 1998, Cancer Res, 58(6): 1285-90.
Gingrich, JR et al, 1996, Cancer res, 56(18): 4096-4102.
Russo, V et al, 1995, Int J Cancer, 64: 216-221.
Yerushalmi et al (Gene, 2001, vol. 265, pp. 55-60).
Caillou et al (Journal of Clinical Endocrinology and Metabolism, 2001, vol. 86, pp. 3351-3358).
EMBL Accession No. AA525010 Jul. 19, 1997.
Blok et al., “Isolation of cDNAs That Are Differentially Expressed Between Androgen-Dependent and Androgen-Independent Prostate Carcinoma Cells Using Differential Display PCT”, The Prostate 1995 26:213-224.
Chang et al., “Differentially Expressed Genes in Androgen-dependent and -independent Prostate Carcinomas”, Cancer Research 1997 57:4075-4081.
Friedrich et al., “Differentiation-Stage Specific Expression of Oncoprotein 18 in Human and Rat Prostatic Adenocarcinoma”, The Prostate 1995 27:102-109.
Hooper et al., “Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors”, Cancer Research 1999 59:3199-3205.
Inoue et al., “Cloning and Tissue Distribution of a Novel Serine Protease esp-1 from Human Eosinophils”, Biochemical and Biophysical Research Communications 1998 252:307-312.
Deguchi, T et al. Detection of Micrometastatic Prostate Cancer Cells in the Bone Marrow of Patients with Prostate Cancer, British Journal of Cancer, 1997, vol. 75, No. 5, pp. 634-638.
An, G. et al. Cloning of Prostate-Specific Genes that are Suppressed In Metastatic Prostate Cancer by a PCR Southern Differential Hybridization Method, Proc. Am. Assoc. Can. Res., vol. 39, p. 208.
Abate-Shen et al., “Nkx3.1; Pten Mutant Mice Develop Invasive Prostate Adenocarcinoma and Lymph Node Metastases1”, Cancer Research 2003 63(14):3886-3890.
Bierberich et al., “Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene”, J. Biol. Chem. 1996 271(50):31779-31782 reprinted as pp. 1-10.
He et al., “A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer”, Genomics 1997 43:69-77.
Herbrand et al., “Transcription factorsNkx3.1andNkx3.2(Bapx1) play an overlapping role in sclerotomal development of the mouse”, Mechanisms of Development 2002 117:217-224.
Kim et al., “Nkx3.1Mutant Mice Recapitulate Early Stages of Prostate Carcinogenesis1”, Cancer Research 2002 62:2999-3004.
Kim et al., “Cooperativity ofNkx3.1andPtenloss of function in a mouse model of prostate carcinogenesis”, Proc. Natl. Acad. Sci. USA 2002 99(5):2884-2889 reprinted as pp. 1-10.
Prescott et al., “Isolation and Androgen Regulation of the Human Homeobox cDNA, NKX3.1”, The Prostate 1998 35:71-80.
Sciavolino et al., “Tissue-Specific Expression of MurineNkx3.1in the Male Urogenital System”, Developmental Dynamics 1997 209:127-138.
NCBI Genbank Accession U80669 [gi:1732377] Dec. 10, 1996-Jun. 3, 1999 with Revision History.
He et al., “A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer”, Genomics 1997 43:69-77 XP-002084749.
López-Otín et al., “Breast and Prostate Cancer:An Analysis of Common Epidemiological, Genetic, and Biochemical Features”, Endocrine Reviews 1998 19(4):365-396 XP-002220464.
Olsson et al., “Reverse Transcriptase-Polymerase Chain Reaction Assays for Prostate Cancer”, Urologic Clinics of North America 1997 24(2):367-377 XP002923009.
Prescott et al., “Isolation and Androgen Regulation of the Human Homeobox cDNA, NKX3.1”, The Prostate 1998 35:71-80 XP-002084750.
Voeller et al., “Coding Region of NKX3.1, a Prostate-Specific Homeobox Gene on 8p21, Is Not Mutated in Human Prostate Cancers1”, Cancer Research 1997 57:4455-4459 XP-002084751.
Database EMBL Human NKX3.1 mRNA, Dec. 17, 1996 Database accession No. HSU80669 XP002084746.
Database EMBL Human NKX3.1 gene, Oct. 15, 2002 Database accession No. NM—006167 XP-002223221.
Deguchi, T et al. Detection of Micrometastatic Prostate Cancer Cells In the Bone Marrow of Patients with Prostate Cancer, British Journal of Cancer, 1997, vol. 75 No. 5, pp. 634-638.
Ali Shujath
Cafferkey Robert
Salceda Susana
Sun Yongming
Davis Minh-Tam
diaDexus, Inc.
Helms Larry R.
Licata & Tyrrell P.C.
McCollum Keith R.
LandOfFree
Method of diagnosing, monitoring, and staging prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing, monitoring, and staging prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing, monitoring, and staging prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024103